Division of Cardiology, Chungnam National University Hospital, Chungnam National University School of Medicine, Daejeon, Republic of Korea.
Division of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Am Heart J. 2020 Jun;224:156-165. doi: 10.1016/j.ahj.2020.03.019. Epub 2020 Mar 25.
Although the need to detect restenosis has diminished in the contemporary practice of percutaneous coronary intervention (PCI) with drug-eluting stents (DES), the surveillance of ischemia owing to restenosis or disease progression deserves attention in high-risk PCI settings. It is unknown whether follow-up strategy of routine noninvasive functional testing potentially reduces the risk of major cardiovascular events in high-risk PCI patients.
The POST-PCI study is an investigator-initiated, multicenter, prospective randomized trial comparing the effectiveness of two follow-up strategies in patients with high-risk anatomic or clinical characteristics who underwent PCI. Study participants were randomly assigned to either (1) the routine noninvasive stress testing (exercise electrocardiography, nuclear stress imaging, or stress echocardiography) at 12 months post-PCI or (2) the standard-care without routine testing. In the routine stress testing group, depending on the testing results, all clinical decisions regarding subsequent diagnostic or therapeutic procedures were at the treating physician's discretion. The primary endpoint was a composite outcome of death from any causes, myocardial infarction, or hospitalization for unstable angina at 2 years post-PCI.
More than 1700 high-risk PCI patients have been randomized over 2.0 years at 11 major cardiac centers in Korea.
This pragmatic POST-PCI trial will provide valuable clinical evidence on the effectiveness of follow-up strategy of routine noninvasive stress testing in high-risk PCI patients.
虽然在药物洗脱支架(DES)经皮冠状动脉介入治疗(PCI)的当代实践中,对再狭窄的检测需求已经减少,但对再狭窄或疾病进展引起的缺血的监测在高危 PCI 环境中值得关注。在高危 PCI 患者中,常规非侵入性功能检测的随访策略是否可能降低主要心血管事件的风险尚不清楚。
POST-PCI 研究是一项由研究者发起的、多中心、前瞻性随机试验,比较了两种随访策略在接受 PCI 治疗的具有高危解剖或临床特征的患者中的有效性。研究参与者被随机分配到以下两种治疗方案之一:(1)在 PCI 后 12 个月进行常规非侵入性应激测试(运动心电图、核应激成像或应激超声心动图);或(2)标准护理而不进行常规测试。在常规应激测试组中,根据测试结果,所有关于后续诊断或治疗程序的临床决策均由主治医生自行决定。主要终点是 PCI 后 2 年时任何原因导致的死亡、心肌梗死或不稳定型心绞痛住院的复合结局。
在 2 年多的时间里,在韩国的 11 个主要心脏中心,超过 1700 名高危 PCI 患者被随机分配到这两个治疗组中。
这项实用的 POST-PCI 试验将为高危 PCI 患者常规非侵入性应激测试的随访策略的有效性提供有价值的临床证据。